Akebia Therapeutics, Inc. - Common Stock (NQ:AKBA)

1.405 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EDT, Apr 17, 2026 Add to My Watchlist

Price and Volume

Volume	0
Open	1.405
Bid (Size)	1.400 (20,000)
Ask (Size)	1.430 (1,300)
Prev. Close	1.405
Today's Range	1.405 - 1.405
52wk Range	1.140 - 4.079
Shares Outstanding	174,537,458
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Akebia (AKBA) Q4 2025 Earnings Call Transcript ↗

February 26, 2026

Akebia (AKBA) Q4 2025 Earnings Call Transcript

Via The Motley Fool

AKBA Shares Rise On Clinical Pipeline Optimism As Anemia Drug Gains Traction ↗

February 26, 2026

The company said on Thursday that it now expects its mid-stage trial of AKB-097 in rare kidney diseases to start in the second half of 2026, with initial data expected in 2027.

Via Stocktwits

Performance

YTD	-9.4%	-9.4%
1 Month	-1.1%	-1.1%
3 Month	+4.9%	+4.9%
6 Month	-55.5%	-55.5%
1 Year	-32.1%	-32.1%

More News

Akebia Therapeutics Inc (NASDAQ:AKBA) Reports Q4 Revenue Beat and 49% Annual Growth Amid Mixed Market Reaction ↗

February 26, 2026

Via Chartmill

Q32 Bio Stock Soars On Selling Experimental Drug To Akeba For Up To $592M ↗

December 01, 2025

Via Stocktwits

Earnings Scheduled For November 10, 2025 ↗

November 10, 2025

Via Benzinga

An Overview of Akebia Therapeutics's Earnings ↗

November 07, 2025

Via Benzinga

Akebia Therapeutics Stock Slumps After FDA Meeting Ends Without Path Forward for Vafseo Label Expansion ↗

October 29, 2025

Via Stocktwits

Earnings Scheduled For August 7, 2025 ↗

August 07, 2025

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

November 10, 2025

Via Benzinga

Top 3 Health Care Stocks Which Could Rescue Your Portfolio In November ↗

November 04, 2025

Via Benzinga

FDA Pushback Prompts Akebia To Drop Broad Label Pursuit For Kidney Disease Drug ↗

October 29, 2025

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

October 29, 2025

Via Benzinga

Earnings Preview For Akebia Therapeutics ↗

August 06, 2025

Via Benzinga

Earnings Scheduled For May 8, 2025 ↗

May 08, 2025

Via Benzinga

Insights Ahead: Akebia Therapeutics's Quarterly Earnings ↗

May 07, 2025

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

October 29, 2025

Via Benzinga

Mondelez International, Stride, Varonis Systems And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗

October 29, 2025

Via Benzinga

Why Teradyne Shares Are Trading Higher By More Than 20%; Here Are 20 Stocks Moving Premarket ↗

October 29, 2025

Via Benzinga

Wondering what's happening in today's after-hours session? ↗

October 28, 2025

Via Chartmill

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

October 28, 2025

Via Benzinga

Akebia (AKBA) Q2 Revenue Jumps 43% ↗

August 07, 2025

Via The Motley Fool

9 Health Care Stocks Whale Activity In Today's Session ↗

June 04, 2025

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

May 08, 2025

Via Benzinga

Here are the top movers in Thursday's session. ↗

March 20, 2025

Via Chartmill

Top movers in Thursday's session ↗

March 20, 2025

Via Chartmill

Frequently Asked Questions

Is Akebia Therapeutics, Inc. - Common Stock publicly traded?

Yes, Akebia Therapeutics, Inc. - Common Stock is publicly traded.

What exchange does Akebia Therapeutics, Inc. - Common Stock trade on?

Akebia Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Akebia Therapeutics, Inc. - Common Stock?

The ticker symbol for Akebia Therapeutics, Inc. - Common Stock is AKBA on the Nasdaq Stock Market

What is the current price of Akebia Therapeutics, Inc. - Common Stock?

The current price of Akebia Therapeutics, Inc. - Common Stock is 1.405

When was Akebia Therapeutics, Inc. - Common Stock last traded?

The last trade of Akebia Therapeutics, Inc. - Common Stock was at 04/17/26 04:00 PM ET

What is the market capitalization of Akebia Therapeutics, Inc. - Common Stock?

The market capitalization of Akebia Therapeutics, Inc. - Common Stock is 245.23M

How many shares of Akebia Therapeutics, Inc. - Common Stock are outstanding?

Akebia Therapeutics, Inc. - Common Stock has 245M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.